74 related articles for article (PubMed ID: 2168493)
1. [Control of interstitial pneumonia with the application of immune transfer].
Otsuka M; Mori T
Rinsho Ketsueki; 1990 May; 31(5):584-8. PubMed ID: 2168493
[TBL] [Abstract][Full Text] [Related]
2. [Antigen-specific antibody response in allogeneic bone marrow transplantation patients: in vivo and in vitro antibody production after the primary immunization with tetanus toxoid. Kanazawa University Bone Marrow Transplantation Team].
Otsuka M; Shiobara S; Harada M; Ueda M; Mori T; Matsue K; Matsuda T
Rinsho Ketsueki; 1990 Mar; 31(3):301-7. PubMed ID: 2366332
[TBL] [Abstract][Full Text] [Related]
3. CMV infections in bone marrow transplanted patients--evaluation of prophylaxis with Cytotect (CMV hyperimmuneglobulin).
Zintl F; Färber I; Hermann J; Fuchs D; Prager J; Wutzler P
Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):557-64. PubMed ID: 2480308
[TBL] [Abstract][Full Text] [Related]
4. Maintenance of immune memory to the hepatitis B envelope protein following adoptive transfer of immunity in bone marrow transplant recipients.
Ilan Y; Nagler A; Zeira E; Adler R; Slavin S; Shouval D
Bone Marrow Transplant; 2000 Sep; 26(6):633-8. PubMed ID: 11035369
[TBL] [Abstract][Full Text] [Related]
5. Antibody responses to tetanus toxoid and Haemophilus influenzae type b conjugate vaccines following autologous peripheral blood stem cell transplantation (PBSCT).
Chan CY; Molrine DC; Antin JH; Wheeler C; Guinan EC; Weinstein HJ; Phillips NR; McGarigle C; Harvey S; Schnipper C; Ambrosino DM
Bone Marrow Transplant; 1997 Jul; 20(1):33-8. PubMed ID: 9232253
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow-resident memory T cells survive pretransplant chemotherapy and contribute to early immune reconstitution of patients with acute myeloid leukemia given mafosfamide-purged autologous bone marrow transplantation.
Casorati G; Locatelli F; Pagani S; Garavaglia C; Montini E; Lisini D; Turin I; Rossi F; Dellabona P; Maccario R; Montagna D
Exp Hematol; 2005 Feb; 33(2):212-8. PubMed ID: 15676215
[TBL] [Abstract][Full Text] [Related]
7. Restricted TCR repertoire and long-term persistence of donor-derived antigen-experienced CD4+ T cells in allogeneic bone marrow transplantation recipients.
Vavassori M; Maccario R; Moretta A; Comoli P; Wack A; Locatelli F; Lanzavecchia A; Maserati E; Dellabona P; Casorati G; Montagna D
J Immunol; 1996 Dec; 157(12):5739-47. PubMed ID: 8955228
[TBL] [Abstract][Full Text] [Related]
8. [Serological diagnosis of cytomegalovirus-induced interstitial pneumonia in patients following bone marrow transplantation].
Müller A; Pustowoit B; Arnold U; Hoffmann FA; Kubel M; Raue I; Friedrich T
Z Gesamte Inn Med; 1991 Aug; 46(12):443-6. PubMed ID: 1659048
[TBL] [Abstract][Full Text] [Related]
9. Kinetics of cytomegalovirus IgG antibody following infusion of a hyperimmune globulin preparation in allogeneic marrow transplant recipients.
Reusser P; Osterwalder B; Gratama JW; The TH; Gratwohl A; Speck B
Bone Marrow Transplant; 1989 May; 4(3):267-72. PubMed ID: 2543469
[TBL] [Abstract][Full Text] [Related]
10. B cell development and regulation after T cell-depleted marrow transplantation.
Wimperis JZ; Brenner MK; Prentice HG; Thompson EJ; Hoffbrand AV
J Immunol; 1987 Apr; 138(8):2445-50. PubMed ID: 3549902
[TBL] [Abstract][Full Text] [Related]
11. A randomized comparison between early and late vaccination with tetanus toxoid vaccine after allogeneic BMT.
Parkkali T; Olander RM; Ruutu T; Vuontela K; Volin L; Eskola J; Ruutu P
Bone Marrow Transplant; 1997 May; 19(9):933-8. PubMed ID: 9156269
[TBL] [Abstract][Full Text] [Related]
12. Comparison of multiple immunization schedules for Haemophilus influenzae type b-conjugate and tetanus toxoid vaccines following bone marrow transplantation.
Vance E; George S; Guinan EC; Wheeler C; Antin JH; Ambrosino DM; Molrine DC
Bone Marrow Transplant; 1998 Oct; 22(8):735-41. PubMed ID: 9827969
[TBL] [Abstract][Full Text] [Related]
13. Interstitial pneumonia after allogeneic and autologous bone marrow transplantation.
Funada H; Harada M; Yoshida T; Hattori K
Jpn J Clin Oncol; 1984 Dec; 14 Suppl 1():519-30. PubMed ID: 6097710
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for cytomegalovirus, hepatitis B and C virus reactivation after bone marrow transplantation.
Zekri AR; Mohamed WS; Samra MA; Sherif GM; El-Shehaby AM; El-Sayed MH
Transpl Immunol; 2004 Dec; 13(4):305-11. PubMed ID: 15589744
[TBL] [Abstract][Full Text] [Related]
15. Adoptive transfer of immunity to hepatitis B virus in mice by bone marrow transplantation from immune donors.
Shouval D; Adler R; Ilan Y
Hepatology; 1993 Jun; 17(6):955-9. PubMed ID: 8514268
[TBL] [Abstract][Full Text] [Related]
16. Salivary immunoglobulins in recipients of bone marrow grafts. II. Transient secretion of donor-derived salivary IgA following transplantation of T cell-depleted bone marrow.
Chaushu S; Chaushu G; Garfunkel A; Slavin S; Or R; Yefenof E
Bone Marrow Transplant; 1994 Dec; 14(6):925-8. PubMed ID: 7711670
[TBL] [Abstract][Full Text] [Related]
17. The effect of T lymphocyte depletion on susceptibility to influenza virus infection and development of anti-viral immunity in lethally irradiated mice reconstituted with syngeneic bone marrow grafts.
Mumcuoglu M; Zakay-Rones Z; Parag G; Weiss L; Slavin S
Bone Marrow Transplant; 1987 Dec; 2(4):403-12. PubMed ID: 3332187
[TBL] [Abstract][Full Text] [Related]
18. Immune transfer studies in canine allogeneic marrow graft donor-recipient pairs.
Grosse-Wilde H; Krumbacher K; Schüning F; Doxiadis I; Mahmoud HK; Emde C; Schmidt-Weinmar A; Schaefer UW
Transplantation; 1986 Jul; 42(1):64-7. PubMed ID: 3523884
[TBL] [Abstract][Full Text] [Related]
19. The potential role of bone marrow transplantation in augmenting donor-derived immunity to hepatitis B after rat liver transplantation.
Li J; Dahmen U; Dirsch OR; Gu Y; Polywka S; Fiedler M; Doebel L; Roggendorf M; Broelsch CE
Liver Transpl; 2002 Apr; 8(4):397-404. PubMed ID: 11965586
[TBL] [Abstract][Full Text] [Related]
20. A randomized study on donor immunization with tetanus-diphtheria, Haemophilus influenzae type b and inactivated poliovirus vaccines to improve the recipient responses to the same vaccines after allogeneic bone marrow transplantation.
Parkkali T; Käyhty H; Hovi T; Olander RM; Roivainen M; Volin L; Ruutu T; Lahdenkari M; Ruutu P
Bone Marrow Transplant; 2007 Feb; 39(3):179-88. PubMed ID: 17211432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
